NovoCure stock forecast
NovoCure (NVCRN) Stock Forecast & Price Target
NVCRN Analyst Ratings
NVCRN Stock 12 Month Forecast
Average Price Target
Mex$440.04▲(77.09% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Wells Fargo | Mex$277.92 | hold | 11.84%Upside | Reiterated | 11/10/26 | ||
| Kevin DeGeeter | Ladenburg Thalmann & Co. | Mex$500.26→Mex$574.37 | buy | 131.14%Upside | Reiterated | 11/10/26 | ||
| Vijay Kumar | Evercore ISI | Mex$426.15→Mex$370.56 | buy | 49.13%Upside | Reiterated | 10/30/26 | ||
| Jason Bednar | Piper Sandler | Mex$537.32 | buy | 116.23%Upside | Reiterated | 10/26/26 | ||
| Emily Bodnar | H.C. Wainwright | Mex$963.46 | buy | 287.73%Upside | Assigned | 07/24/26 | ||
| David Nierengarten | Wedbush | Mex$333.51→Mex$370.56 | hold | 49.13%Upside | Reiterated | 07/24/26 | ||
| Jessica Fye | J.P. Morgan | Mex$314.98 | hold | 26.76%Upside | Reiterated | 07/13/26 | ||
| Jonathan Chang | Leerink Partners | Mex$444.68 | buy | 78.95%Upside | Reiterated | 01/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystWells FargoNot Ranked | HoldReiteratedMex$277.92 | 11/10/26 | 11.84%Upside | ||
| Kevin DeGeeterLadenburg Thalmann & Co. | BuyReiteratedMex$500.26→Mex$574.37 | 11/10/26 | 131.14%Upside | ||
| Vijay KumarEvercore ISI | BuyReiteratedMex$426.15→Mex$370.56 | 10/30/26 | 49.13%Upside | ||
| Jason BednarPiper Sandler | BuyReiteratedMex$537.32 | 10/26/26 | 116.23%Upside | ||
| Emily BodnarH.C. Wainwright | BuyAssignedMex$963.46 | 07/24/26 | 287.73%Upside | ||
| David NierengartenWedbush | HoldReiteratedMex$333.51→Mex$370.56 | 07/24/26 | 49.13%Upside | ||
| Jessica FyeJ.P. Morgan | HoldReiteratedMex$314.98 | 07/13/26 | 26.76%Upside | ||
| Jonathan ChangLeerink Partners | BuyReiteratedMex$444.68 | 01/13/26 | 78.95%Upside |
Best Analysts Covering NovoCure
Copying Jason Bednar's trades and holding each position for 3 Months would result in 53.13% of your transactions generating a profit, with an average return of +7.19% per trade.
Copying Jason Bednar's trades and holding each position for 1 Year would result in 34.38% of your transactions generating a profit, with an average return of +3.37% per trade.
Copying Emily Bodnar's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -19.11% per trade.
NVCRN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 3 | 2 | 3 |
| Buy | 2 | 0 | 0 | 0 | 0 |
| Hold | 6 | 4 | 2 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 9 | 5 | 3 | 5 |
In the current month, NVCRN has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. NVCRN average Analyst price target in the past 3 months is 440.04.
NVCRN Financial Forecast
NVCRN Earnings Forecast
Next quarter’s earnings estimate for NVCRN is -MXN 4.00 with a range of -MXN 4.65 to -MXN 3.53. The previous quarter’s EPS was -MXN 1.67. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NVCRN Sales Forecast
Next quarter’s sales forecast for NVCRN is MXN 3.53B with a range of MXN 3.48B to MXN 3.56B. The previous quarter’s sales results were MXN 3.60B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
